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AbstrACt
Objectives To explore general practitioner (GP) and 
ears, nose and throat (ENT) specialist perspectives of 
current treatment strategies for chronic rhinosinusitis 
(CRS) and care pathways through primary and 
secondary care.
Design Semi-structured qualitative telephone interviews 
as part of the MACRO programme (Defining best 
Management for Adults with Chronic Rhinosinusitis)
setting Primary care and secondary care ENT outpatient 
clinics in the UK.
Participants Twelve GPs and 9 ENT specialists consented 
to in-depth telephone interviews. Transcribed recordings 
were managed using NVivo software and analysed using 
inductive thematic analysis.
Main outcome measures Healthcare professional views 
of management options and care pathways for CRS.
results GPs describe themselves as confident in 
recognising CRS, with the exception of assessing nasal 
polyps. In contrast, specialists report common missed 
diagnoses (eg, allergy; chronic headache) when patients 
are referred to ENT clinics, and attribute this to the 
limited ENT training of GPs. Steroid nasal sprays provide 
the foundation of treatment in primary care, although 
local prescribing restrictions can affect treatment choice 
and poor adherence is perceived to be the causes of 
inadequate symptom control. Symptom severity, poor 
response to medical treatment and patient pressure 
drive referral, although there is uncertainty about optimal 
timing. Treatment decisions in secondary care are based 
on disease severity, polyp status, prior medical treatment 
and patient choice, but there is major uncertainty about 
the place of longer courses of antibiotics and the use 
of oral steroids. Surgery is regarded as an important 
treatment option for patients with severe symptoms or 
with nasal polyps, although timing of surgery remains 
unclear, and the uncertainty about net long-term benefits 
of surgery makes balancing of benefits and risks more 
difficult.
Conclusions Clinicians are uncertain about best 
management of patients with CRS in both primary and 
secondary care and practice is varied. An integrated 
care pathway for CRS is needed to improve patient 
management and timely referral.
IntrODuCtIOn  
Chronic rhinosinusitis (CRS) is a preva-
lent chronic inflammatory condition of the 
nose and paranasal sinuses which signifi-
cantly affects the health and quality of life 
of patients,1 2 and contributes a significant 
burden to the National Health Service 
healthcare resources. CRS is defined in the 
European Position Paper on Rhinosinusitis 
(EPOS 2012)3 by the presence of at least two 
symptoms, one of which must be either nasal 
congestion or nasal discharge together with 
facial pain/pressure and/or anosmia lasting 
for >12 weeks. This is then further qualified by 
the presence (CRSwNP) or absence of nasal 
polyps (CRSsNP). Based on the symptom and 
duration definition alone, prevalence rates 
are estimated at 10% in the UK.4 Longitu-
dinal data from the Clinical Practice Research 
Datalink suggests that 1% of British adults 
receive treatment each year in primary care, 
resulting in multiple GP consultations and 
medical prescriptions.5 There is significant 
strengths and limitations of this study
 ► The interviews permitted exploration of diagnosis, 
treatment and management strategies for patients 
with chronic rhinosinusitis (CRS) through primary 
and secondary care.
 ► Participants were sampled from different geographi-
cal areas of England and Scotland, enhancing trans-
ferability of the study findings.
 ► The inclusion of generalist and specialist views pro-
vided a better understanding of CRS management 
from multiple perspectives.
 ► Including other clinicians such as ears, nose and 
throat specialty doctors and primary care nurse 
practitioners may have provided an additional 
viewpoint.
 ► Patient views and experiences are not included but 
are presented elsewhere.
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onward referral to specialist ears, nose and throat (ENT) 
services leading to 120 000 outpatient appointments and 
40 000 sinus operations annually in England and Wales.6 
To date, there are no National Institute for Health 
and Care Excellence (NICE) guidelines for managing 
patients with CRS. International7 and European (EPOS) 
guidelines3 are present, however, awareness and uptake 
in UK practice is unclear. Commissioning guidelines8 for 
management of rhinosinusitis were developed in collab-
oration with the Royal College Of Surgeons England 
and NICE, but local compliance with guidelines is vari-
able and access to specialist care is restricted in some 
areas. Intranasal corticosteroids (INCS) and nasal irri-
gation are strongly recommended based on high-quality 
evidence,9–11 however there are uncertainties about 
uptake and compliance in primary care. Most consulta-
tions with general practitioners (GPs) for acute or chronic 
rhinosinusitis result in an antibiotic prescription despite 
insufficient evidence for routine use.12 Uncertainties in 
secondary care result in a fivefold variation in surgical 
rates around the UK6 and there is conflicting evidence 
for the use of long-term antibiotics.13
The views and experiences of healthcare professionals 
involved in the CRS patient pathway have yet to be investi-
gated in depth. As yet, no studies have explored GP prac-
tice variation in terms of knowledge of the guidelines, 
treatment decisions and referral criteria, and there is 
limited understanding of ENT specialist views and experi-
ences of treating patients with CRS.
The MACRO programme (Defining best Manage-
ment for Adults with Chronic Rhinosinusitis) 14 is the 
National Institute for Health Research (NIHR) funded 
programme of research designed to establish best prac-
tice for CRS management in adults across primary and 
secondary care. This paper reports a qualitative interview 
study, conducted as part of the MACRO programme, 
exploring GP and ENT specialist views of current treat-
ment strategies and care pathways for patients with CRS 
through primary and secondary care.
MethODs
Design
A qualitative interview study was conducted with a 
purposeful sample of GPs and ENT specialists between 
January and April 2017.
Participants and procedures
GPs were approached through the NIHR Clinical 
Research Network in regions of Wessex, Eastern and 
South East England. Fifteen interested GPs with expe-
rience of treating patients with CRS responded to the 
study team and were purposefully sampled for a range of 
characteristics including gender, GP experience, practice 
location and practice population demographics.
ENT specialists with experience of treating patients with 
CRS were recruited through an email to the membership 
of ENT-UK (the professional body representing ENT 
surgeons). Thirty-one ENT specialists from England 
and Scotland expressed an interest in participating and 
were purposefully sampled for a range of demographics 
(location, time in practice) and ENT subspecialty interest 
(including generalists and rhinologists).
Interviews
A trained interviewer (JV) conducted semi-structured tele-
phone interviews with participants each lasting approxi-
mately 25–55 min. JV (female) is a postdoctoral research 
fellow for the MACRO programme, trained in qualitative 
research methods and with previous experience of ENT and 
primary care research, who was not previously known to the 
interview participants. Telephone interviews were employed 
to allow inclusion of participants from a wide geograph-
ical area. Each participant gave verbal consent prior to 
commencing the interview. An interview guide (see online 
supplementary appendix 1) was developed through collab-
oration and input from the wider MACRO research team, 
and subsequently piloted with an ENT specialist and minor 
modifications made to reflect any issues that arose. The 
guide was used to direct but not constrain the interviews and 
was sufficiently flexible to allow exploration of unexpected 
topics and themes. Field notes were used to facilitate inter-
pretation and contextualisation of the interviews.
GPs and ENT specialists were asked open-ended ques-
tions about their views of the diagnosis and management 
of CRS, knowledge and implementation of CRS guide-
lines, perceptions of the evidence base and experiences 
of practical decision-making in the management of 
patients with CRS. The interviews were audio-recorded 
and transcribed verbatim in preparation for analysis. Our 
epistemological position is one of subtle realism, and a 
pragmatic approach was adopted in this study.
Analysis
Inductive thematic analysis15 was used to analyse the 
interview transcripts, using NVIVO 11 to facilitate data 
management. Each participant group (GPs and ENT 
surgeons) were analysed independently. Each analysis 
commenced with familiarisation and immersion in the 
data itself, leading to identification of initial patterns and 
themes within the data set. Descriptive codes were then 
used to label sections of the data. A number of transcripts 
were coded by more than one researcher (JV and CE). 
which brings multiple perspectives to the analysis and 
provides an opportunity to discuss coding decisions at an 
early stage. Codes were then developed and refined as 
analysis progressed, and where uncertainties arose, team 
discussions facilitated agreement and adjustment. These 
codes were then linked together, grouped, refined and 
re-labelled resulting in a set of themes and subthemes for 
each participant group. Following an iterative process of 
comparing and contrasting the two datasets, a set of over-
arching themes and subthemes were developed which 
systematically and thoroughly explained the data. Data 
collection and analysis took place concurrently, and inter-
views continued until data saturation was achieved.
 o
n
 20 Decem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022643 on 19 December 2018. Downloaded from 
3Vennik J, et al. BMJ Open 2018;8:e022643. doi:10.1136/bmjopen-2018-022643
Open access
Patient involvement
A patient contributor (JB) from the MACRO programme 
management group provided input into the design of the 
study from the patient perspective, and contributed to 
the development of the interview topic guide.
results
Participants
A total of 12 GPs participated in the study. Eight (76%) 
were male with median duration in general practice of 
20 years (range 2–29). Included GPs were from rural 
and urban practices, from areas of differing social depri-
vation. Nine ENT specialists including general ENT 
surgeons and rhinologists also took part in a research 
interview; eight were male with a median time on the 
specialist register of 19 years (range 8–21). Full details are 
presented in table 1.
themes
Thematic analysis identified four main themes relating 
to the management of patients with CRS (table 2). 
Quotations are presented to illustrate the themes and 
subthemes, with details of the participants presented in 
parentheses.
theme 1: diagnostic uncertainties
Reaching a diagnosis
GPs describe themselves as confident in recognising CRS, 
making a diagnosis based on patient-reported history of 
symptoms and impact on quality of life, together with a 
basic physical examination of the nose. Duration of symp-
toms was described as an important diagnostic factor, 
although there is some uncertainty in primary care about 
the definition of chronicity.
Then I guess really the diagnosis comes down to the 
time course more than anything. Assuming that that 
cluster of symptoms is present, it comes down to the 
time course. (GP 04)
On the contrary, ENT specialists describe primary 
care diagnosis of CRS as of variable quality and preci-
sion, with many patients presenting at ENT clinics with a 
misdiagnosis.
So I think, therefore, their diagnostic ability for ENT 
conditions, broadly, and rhinosinusitis in particular, 
can be very poor. (ENT 01)
Uncertainties can arise when symptoms overlap with 
other conditions, such as chronic headaches and allergic 
rhinitis, which can lead to patients receiving ineffective 
treatments.
We see lots of patients who are referred with ‘recur-
rent sinus infections’ where their main presenting 
symptom may be facial pain or headache, and most 
of those patients, in my experience, with those symp-
toms, don't have rhinosinusitis. (ENT 02)
ENT specialists also describe a diagnostic challenge 
where there is a dissociation between patient symptom 
history and clinical findings.
There's a well-defined group of patients who have 
symptoms which are on history virtually indistinguish-
able from CRS who actually have nothing on nasal 
endoscopy, in other words completely normal nasal 
endoscopy, and when the CT scan comes back that's 
completely normal as well. (ENT 05)
Table 1 Participant characteristics
GP characteristics n=12
Years in general practice (median, range) 20 (2–29)
Male 8
Practice list size mean (range) 9967 (4758–18 571)
Practice deprivation decile (where 1 is most deprived, 
10 is least deprived) median (range)
9 (3–10)
Practice location 
  Rural town and fringe 4 
  Rural village and dispersed 1
  Urban city and town 4
  Urban major conurbation 3
ENT specialist characteristics n=9
Time (years) on specialist register (otolaryngology) 
(median, range)
19 (8–21)
Male 8
Subspecialisation 
  General ENT surgeon 3
  Special interest in rhinology 4
  Consultant rhinologist 2
Location 
  Yorkshire and Humberside 1
  Midlands 1
  London 1
  South East 4
  Scotland 2
ENT, ears, nose and throat.
Table 2 Themes and subthemes
Theme Subtheme
1. Diagnostic uncertainties  ► Reaching a diagnosis
 ► Distinguishing between subgroups
2. Selecting best management  ► Treatment decisions
 ► Initiation treatment in primary care
 ► Further medical treatment options
3. Decision-making for surgery  ► Implementing guidelines
 ► Value of sinus surgery
 ► Joint decision-making
4. Transition of care  ► Factors affecting referral
 ► Quality of referral
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Distinguishing between subgroups
GPs report some difficulties in diagnosing patients with 
nasal polyps unless polyps are visible in the nasal cavity, 
due to the lack of diagnostic equipment in primary care.
Yes, with polyps, on the outset, if we have a patient 
with these symptoms, to sort of diagnose polyps is 
very difficult for us unless they've got a previous di-
agnosis. (GP 08)
In contrast, ENT specialists report the diagnosis of CRS 
without nasal polyps to be more challenging particu-
larly when there is an absence of clinical findings on 
examination.
The diagnosis of chronic rhinosinusitis without na-
sal polyps is really, really difficult. As I say, some of 
them will actually have pus dripping from their sinus 
into the nose, and that's very easy, but the majority of 
them don't have that at all. (ENT 08)
theme 2: selecting best management
Treatment decisions
GPs report using local guidelines, journal articles, online 
learning modules and GP educational sessions to keep 
up to date with current practices. However, GP update 
courses are described as often too general and cover a 
broad range of topics. Events provided by the local ENT 
department were described as extremely useful but were 
infrequent.
I tend to do a lot of online stuff, so I'll look at BMJ 
or RCGP learning. Sometimes, we get local events. 
We've not had a local ENT event recently, but we do 
get local consultants or specialist nurses, sometimes, 
come out and give us updates and guidelines. (GP 
05)
GPs also describe ENT clinic letters as useful and 
informative about current practice for managing patients 
with CRS.
You get a flavour of reading letters and so you get an 
idea of what they recommend in their letters. (GP 09)
Nonetheless, ENT specialists expressed opinion that 
GPs have limited ENT training and some are poorly 
trained to recognise and understand symptoms and 
pathology of CRS.
Most GPs have never done any ENT jobs, ever, in their 
training. Most medical students don't get any ENT 
teaching, or very minimal ENT teaching, so you then 
have a sub-set of GPs who don't know any ENT unless 
it's what they've been told by their GP colleagues on 
the odd course they go to. (ENT 01)
Initiating treatment in primary care
INCS were commonly described as first-line treatment 
for patients with CRS, with the choice often associated 
with GP preference and experience. However, some GPs 
describe local prescribing restrictions where they are 
directed to prescribe lower cost nasal sprays such as beclo-
methasone, instead of more costly fluticasone, in the first 
instance.
There will pop up a box (on our computers) saying, 
'This costs this much, why don't you use this one 
which costs only this much?' So we're constantly re-
minded to use cost effective things. (GP 02)
However, both GPs and ENT specialists suggested that 
patients did not always apply their nasal sprays correctly 
or did not comply with the treatment regimen over a 
longer period of time.
It's quite obvious that they have been sniffing too 
much and it's gone all the way to the back of the 
throat, and they're using it incorrectly, maybe be-
cause no one informed them of how to use it in the 
past. (GP 06)
GPs describe prescribing short courses of antibiotics for 
patients with acute infection, purulent discharge, febrile 
patients and for those who are most severely affected. 
However, some GP report feeling pressured by patients to 
prescribe antibiotics, especially if symptoms are particu-
larly severe or the patient has responded to antibiotics in 
a previous episode.
The biggest challenge is patients wanting antibiotics 
because they think that will cure everything! (GP 05)
Most GPs reported limited use of saline irrigation 
in primary care. Despite recommendations from ENT, 
GPs were unfamiliar with the evidence and therefore 
unlikely to recommend them to patients, or patients were 
concerned about the cost of proprietary preparations.
ENT doctors recommend it (saline irrigation) to pa-
tients, but that's not something I'd recommend my-
self…I just wasn't aware if it was evidence-based, or if 
it was something we should be recommending. (GP 
09)
Further medical treatment options
Some ENT specialists report the use of long-term antibi-
otics for patients with CRS, although there is uncertainty 
about which patients might benefit and the optimum 
length of treatment.
I think the issue is about what is the role of long-term 
antibiotics in rhinosinusitis and particularly the clar-
ithromycin group of antibiotics? It is something I am 
aware of being used increasingly and I do now use in 
some patients. (ENT 02)
There is a mixed opinion about whether long-term 
antibiotics are appropriate for patients with CRS with 
nasal polyps, with some ENT specialists describing them 
as ineffective, and a lack of evidence for their routine use. 
Others, however, recount prescribing low-dose antibiotics 
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alongside oral steroids for nasal polyps prior to consider-
ation for surgery.
I don't use clarithromycin for polyps. I know some 
people do but I don't because from my reading of 
the literature and all that I don't really see any of the 
benefit. (ENT 07)
Most GPs reported being unfamiliar with long term 
antibiotic use for CRS in primary care, and some were 
concerned about the potential for side effects.
I don't have any experience of it. I'm not keen on 
long term courses of antibiotics, for this particular 
condition. (GP 07)
GPs described infrequent use of oral steroids in primary 
care. ENT specialists report the use of oral steroids in the 
preoperative pathway for patients with polyp disease. A 
rescue course of oral steroids is sometimes used for severe 
patients when symptoms are uncontrolled. Oral ster-
oids were reported as rarely recommended for patients 
without nasal polyps.
I think most people would say that the polyp group 
need a lot more oral steroid and a lot less antibiotic, 
and the non-polyp group need a lot less steroid and a 
lot more antibiotic, in general terms. (ENT 08)
theme 3: decision-making for surgery
Implementing guidelines
ENT specialists keep up to date with current practices in 
CRS by reading rhinology journals and attending ENT 
conferences. All ENT specialists were familiar with the 
EPOS guidelines and described them as a good source of 
evidence for diagnosis and treatment decisions, although 
most general ENT surgeons did not refer to them on a 
daily basis.
So generally EPOS guidelines are probably the thing 
that I pay the most attention to. (ENT 09)
Value of sinus surgery
ENT specialists describe sinus surgery as an important 
treatment for patients with severe disease, and when 
medical treatment options have been explored.
Well, I think the patients at the more severe end of 
the spectrum, I think it offers them the best chance 
of a long-term improvement in symptoms. (ENT 05)
Similarly, GPs viewed sinus surgery as a treatment 
option which should be reserved for more severe patients 
who have tried all available medical treatments.
I think there is a role for surgery but I'm not some-
one who likes intervention. So, I would, initially, try 
all the things, the nasal therapies, basically, to see if 
that does the job first. Surgery is a last resort, for me. 
(GP 07)
However, some specialists describe uncertainties about 
the value of a surgical intervention for an inflammatory 
condition.
I'm not intellectually massively impressed by it, if I'm 
absolutely honest with you, the idea of doing an oper-
ation to help a mucosal inflammatory problem. (ENT 
08)
ENT specialists identify the role of surgery in polyp 
disease and report prioritising these patients for surgical 
intervention.
The severe polyp patients, the ones who are com-
pletely bunged up, I wouldn't bother with any of the 
medical therapy. I just put them on my operating list 
for surgery. (ENT 05)
Both GPs and ENT specialists view surgery as a tempo-
rary rather than permanent solution for CRS. ENT 
specialists recount that most patients require ongoing 
medical treatment to manage symptoms after surgery, 
and GPs describe surgery as rarely a long-term solution 
for patients with CRS.
I mean I think it's rare that surgery is curative for 
those people, I would say, they don’t just go and have 
one operation and never have any problems with 
their nose and sinuses for the rest of their life! These 
patients come back and back, even when they've had 
surgery. (GP 02)
Joint decision-making
ENT specialists reported that decision-making for surgery 
is made jointly with the patient after all treatment options, 
risks and potential benefits have been discussed.
It's very much up to the patients. Our patients are a 
very switched on bunch of people. They totally like to 
be involved in their decision. (ENT 09)
However, both GPs and ENT specialists recognise that 
some patients have a high expectation for surgery while 
others express a reluctance for surgery, especially repeat 
surgery.
Then there are some people who definitely want sur-
gery from the outset, and don't want to have medi-
cal therapy, and they're difficult to manage because 
they won't accept a trial of medical therapy, because 
they've had antibiotics before and they've had those 
sprays and those drops, and they don't work. (ENT 
01)
Some GPs describe advising patients against surgery 
due to the possible complications, side effects and poten-
tially limited benefits.
I tend to counsel people fairly strongly against having 
sinus surgery because I just don't believe it's a long-
term benefit in the vast majority of cases. (GP 04)
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Both GPs and ENT specialists recognise the potential 
risks of sinus surgery and describe the importance of 
balancing these against uncertain symptomatic relief for 
patients.
ENT surgery is painful, causes people to have a lot of 
time off work and may not yield high benefit and may 
make the problem worse. So I would have thought 
that that should come at a later stage, so not to cause 
harm. (GP 01)
theme 4: transition of care
Factors affecting referral
GPs use their clinical judgement when deciding either to 
continue to manage a patient in primary care or to refer 
for specialist opinion and further treatment options. 
The impact of symptoms on a patient’s quality of life and 
response to medical treatments were recognised by GPs 
as important factors for referral.
It really hinges, I think, on whether they're getting 
better with the simple treatment that we've put in 
place. If they're not getting better and it's affecting 
them and having effect on their functioning and 
their quality of life, then I would refer them. (GP 
11)
GPs explained that patients with visible nasal polyps 
and those with structural abnormalities were priori-
tised for referral due to the potential need for surgical 
intervention.
I would refer someone if they had obstructing pol-
yps that hadn't responded to medical polypectomy, 
assuming that they wanted to have a surgical polyp-
ectomy. (GP 04)
Some GPs report patient pressure for early referral, 
although many GPs report giving patients the choice 
about continued treatment in primary care or referral for 
a specialist opinion.
In some instances where they're adamant that they 
want to see a specialist, then we've had to write direct-
ly to the clinic and bypassing the referral to say that 
specifically this patient is wanting to see a specialist. 
(GP 08)
Many GPs were unaware of local referral guidelines for 
CRS and based their decision for referral on personal 
experience. However, others described a referral triage 
system or a local referral support service who screen the 
referral against local guidelines.
So, for the referral form, the guidelines are actually 
attached to that. So, at the point of referral, you can 
actually have a look at that and see if this patient fits 
or if there is more for you to do before it gets to ENT. 
(GP 07)
Quality of referral
ENT specialists report wide variation in the timing and 
quality of GP referrals to secondary care. Some specialists 
observed a delay in referral when symptoms are severe 
and suggest that earlier referral would be easier to treat 
and result in better outcomes for patients.
So I quite frequently see patients that have suffered 
symptoms for many months, if not years. It's a very 
frequent comment that I get from patients, saying 
I've been trying to get referred to a specialist for ages 
and ages and they just won't refer me and they just 
give me nose drops and sprays. (ENT 05)
Equally, other specialists report cases of premature 
referral, when patients have not received maximal avail-
able medical treatment in primary care.
I think I might criticise them for referring too pre-
sumptuously because I think we do get referrals from 
GPs who haven't actually even initiated medical ther-
apy. (ENT 02)
DIsCussIOn
synopses of key findings
This study explored GPs and ENT specialist views of 
current practice for managing patients with CRS. GPs 
describe themselves as confident in recognising CRS with 
the exception of nasal polyps, however, surgeons report 
common missed diagnoses when patients are referred to 
ENT clinics and attribute this to the limited ENT training 
of GPs and lack of available diagnostic tests or equipment. 
Local prescribing restrictions can affect choice of INCS 
in primary care and poor adherence is perceived to be 
the causes of inadequate symptom control. Symptom 
severity, poor response to medical treatment and patient 
pressure drives referral, although there is lack of clarity 
about optimal timing. ENT clinic letters are a valuable 
information source for GPs and ENT training courses are 
useful but infrequent. Treatment decisions in secondary 
care are based on disease severity, polyp status, prior 
medical treatment and patient choice. Long-term anti-
biotic use is variable and specialists are uncertain about 
optimal dosing and which patients might benefit. Surgery 
is regarded as an important treatment option for patients 
with severe symptoms and especially in those with nasal 
polyps, although timing of surgery remains unclear, and 
the uncertainty about net long-term benefits of surgery 
makes balancing of benefits and risks more difficult.
Comparison with current literature
GP management
The findings of this study suggests that there is wide varia-
tion in the diagnosis and management of CRS in primary 
care in the UK, which is likely to be due to limited ENT 
training and insufficient national guidance. It has been 
long recognised that GPs receive limited ENT training 
at both undergraduate and postgraduate level16 and this 
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is particularly important in light of the number of ENT 
conditions that are initially seen in general practice. Our 
findings agree with previous research that GPs would like 
further ENT training,17 and that regional courses and 
updates might be useful to improve knowledge, clinical 
skills and referral pathways to secondary care.
INCS are commonly prescribed for CRS; however, our 
research identified local prescribing restrictions and that 
both adherence and adequacy of correct nasal spray use 
by patients was perceived to be extremely variable. These 
findings support the results of a case-control study in the 
UK, which found that current INCS usage is <15% in 
patients with CRS, and only 1% of patients regularly use 
saline nasal irrigation.18 Such usage may result in poor 
symptom control and untimely referral. Reasons for low 
usage are likely to be multifactorial. Previous qualitative 
work has identified that patients can be dissatisfied with 
topical treatments due to their perceived ineffective-
ness19 and concern about potential side effects.20 Simi-
larly, nasal irrigation was not widely advocated by GPs in 
this study due to uncertainties about effectiveness and 
a perceived burden for patients. However, there is now 
evidence from a recent trial which found nasal irrigation 
to be acceptable to patients with recurrent or chronic 
rhinosinusitis and provides symptomatic benefit in the 
primary care setting.21 22 Currently in the UK, nasal irriga-
tion kits cannot be prescribed by GPs as they are consid-
ered medical devices rather than medicines, so have to be 
purchased by patients and costs may deter uptake.
Some GPs described uncertainty about the optimal 
timing of referral, with wide variation in practice and a 
lack of clarity about referral criteria for both CRSsNP 
and CRSwNP. Correspondingly, ENT specialists reported 
variation in timing and precision of referral, expressing 
concerns that some patients experience unnecessarily 
delays, while others were referred too early and without 
trials of basic medical treatment. The EPOS guidelines3 
recommend referral in patients where no improvement 
has been achieved after 4 weeks of treatment with INCS 
and nasal irrigation. However, knowledge and uptake of 
the European guideline is understandably variable in 
UK primary care. An audit of Clinical Commissioning 
Groups (CCGs) in England found that compliance with 
CRS commissioning was limited in 13% of CCGs.23 It may 
be that such guidance is not perceived in the same way 
that NICE guidance is viewed, affecting management and 
referral decisions, and fostering the variation of practice 
reported in this study. Similarly, in Dutch general prac-
tice, management of patients with CRS has been reported 
inconsistent and not always in accordance with local 
guidelines.24
ENT management
Our study highlighted wide variation in diagnostic 
criteria and management decisions for CRS even among 
ENT specialists. Practice variation in usage of long-term 
antibiotics and timing of sinus surgery suggest that there 
is a lack of clarity around the evidence base for treatment 
of both CRSsNP and CRSwNP. There remains a paucity of 
evidence for sinus surgery, and more research is required 
to understand best timing, although emerging evidence 
shows that surgery undertaken closer to the time of diag-
nosis may improve long-term outcomes both in terms 
of symptoms and late-onset asthma.25 26 There is also a 
perception among GPs and ENT specialists in this study 
that surgery was not of any long-term benefit and that 
patients will simply keep returning; this is of course borne 
out by the high revision rate seen in two UK national 
studies.27 28 A key part of this issue is the postoperative 
care and compliance with topical treatment. The forth-
coming trial in the MACRO programme14 will address 
the role of sinus surgery in a randomised controlled 
trial context which has not been done to date, despite 
many case series showing favourable outcomes, including 
the UK Sinonasal audit.29 There will also be a long-term 
plan to follow-up the patients beyond the trial so that the 
benefits of sinus surgery beyond the short-term can be 
addressed.
Implications for practice
In view of the currently fragmented and diverse situa-
tion, there is a need to clarify care pathways for CRSwNP 
and CRSsNP across primary and secondary care. Devel-
opment of an evidence-based integrated care pathway, 
informed by patient, generalist and specialist perspec-
tives, may help to improve management of patients with 
CRS. Communication between ENT and general practice 
needs enhancing, and clarification of diagnostic, treat-
ment and referral algorithms has the potential to improve 
early management and precision of referral. Improving 
the information to both patients and clinicians as to the 
appropriate use of both medical and surgical interven-
tions to best effect, including addressing rationale for 
treatment options, safety, technique, compliance and 
dispelling misperceptions around the various treatment 
options, has the potential to improve outcomes and 
reduce variation and costs.
strengths and limitations
A key strength of this study was the inclusion of both 
generalist and specialist views from representative samples 
of frontline clinicians, to provide a better understanding 
of the CRS patient pathway from multiple perspec-
tives, which have not been captured in previous studies. 
However, it is possible that our sample of clinicians were 
particularly interested in CRS or research of this nature 
and thus their views may not have represented those of 
the non-respondents.
A good level of thematic data saturation was achieved 
with our sample of participants, but we acknowledge 
that the views of other stakeholders such as nurse prac-
titioners in primary care and ENT specialty doctors may 
have provided an additional viewpoint.
Additionally, the views and experiences of patients with 
CRS are important in understanding the patient journey 
and these are presented elsewhere.
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This study used rigorous methods to ensure credibility 
and trustworthiness of the findings, including multiple 
coders, constant comparison techniques and maintained 
a transparent audit trail.
COnClusIOn
In summary, this qualitative study found that clinicians 
are uncertain about best management of patients with 
CRS in both primary and secondary care, and there is 
wide variation in practice. Improved communication 
between ENT and general practice together with an 
evidence-based integrated care pathway for CRSsNP and 
CRSwNP is needed to improve CRS patient management 
and timely referral.
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